When comparing Semaglutide, Metformin, and Tirzepatide, its important to evaluate their individual effectiveness, side effects, and how they align with your specific health goals
Ongoing phase III studies include patients with T2D with an eGFR of at least 3045 mL/min/1.73m 2 , while also permitting severe renally impaired and ESRD patients in one of the studies
It can be administered at any time of day, with or without meals
Shahzaib Ahmad MBBS, BSc, MRCP, FRCA, FFICM Clinical Supervisor - Vitall|GMC 7495062|Profile Reviewed on 09/06/2026 Next review due 09/06/2027 Review focus: Blood biomarkers, laboratory testing methodology, and biochemical interpretation
Acarbose is often used off-label in longevity protocols to improve metabolic and gut health, even in non-diabetics